Laboratory tests and imaging studies in patients with cutaneous malignant melanomas: A survey of experienced physicians

Journal of the American Academy of Dermatology

Volumn 36, Issue 5 I, 1997, Pages 711-720

  Provost, N ^a   Marghoob, A A ^a   Kopf, A W ^a   DeDavid, M ^a   Wasti, Q ^a   Bart, R S ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER STAGING; CLINICAL PRACTICE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; HUMAN; LABORATORY TEST; LIVER FUNCTION TEST; MELANOMA; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCULT CANCER; PRIORITY JOURNAL; PROGNOSIS; QUESTIONNAIRE; THORAX RADIOGRAPHY;

EID: 0031010930     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(97)80323-4     Document Type: Article

References (57)

1. Ries L.A.G. Miller B.A. Hankey B.F. SEER Cancer Statistics Review, 1973 1991: Tables and Graphs, National Cancer Institute 1994 National Cancer Institute Bethesda, MD
2. Parker S.L. Tong T. Bolden S. Cancer statistics, 1996 CA Cancer J Clin 65 1996 5 27
3. Salopek T.G. Marghoob A.A. Slade J.M. An estimate of the incidence of malignant melanoma in the United States: based on a survey of members of the American Academy of Dermatology Dermatol Surg 21 1995 301 305
4. Beahrs O.H. Henson D.E. Hufter R.V.P. Manual for staging of cancer 4th ed. 1992 JB Lippincott Philadelphia 143 147
5. Breslow A. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma Ann Surg 172 1970 902 908
6. Clark W.H. Jr. From L. Bernardino E.A. The histogenesis and biologic behavior of primary human malignant melanomas of the skin Cancer Res 29 1969 705 727
7. Balch C.M. Soong S.-j. Shaw H.M. An analysis of prognostic factors in 8500 patients with cutaneous melanoma Balch C.M. Houghton A.N. Milton G.W. Cutaneous melanoma 2nd ed. 1992 JB Lippincott Philadelphia 165 199
8. Garbe C. Buttner P. Bertz J. Primary cutaneous melanoma: identification of prognostic groups and estimation of individual prognosis for 5093 patients Cancer 75 1995 2484 2491
9. Balch C.M. Soong S.-j. Shaw H.M. An analysis of prognostic factors in 8500 patients with cutaneous melanoma Balch C.M. Houghton A.N. Milton G.W. Cutaneous melanoma 2nd ed. 1992 JB Lippincott Philadelphia 439 467
10. Patel J. Didolkar M. Pickren J. Metastatic pattern of malignant melanoma: a study of 216 autopsy cases Am J Surg 135 1978 807 810
11. Kelly J.W. Blois M.S. Sagebiel R.W. Frequency and duration of patient follow-up after treatment of a primary malignant melanoma J Am Acad Dermatol 13 1985 756 760
12. Romero J.B. Stefanato C.M. Kopf A.W. Follow-up recommendations for patients with Stage I malignant melanoma J Dermatol Surg Oncol 20 1994 175 178
13. Marghoob A.A. Slade J. Kopf A.W. Risk of developing multiple primary cutaneous melanomas in patients with the classic atypical-mole syndrome: a case-control study Br J Dermatol 135 1996 704 711
14. Shumate C.R. Urist M.M. Maddox W.A. Melanoma recurrence surveillance: Patient or physician based? Ann Surg 221 1995 566 569
15. Weiss M. Loprinzi C.L. Creagan E.T. Utility of follow-up tests for detecting recurrent disease in patients with malignant melanomas JAMA 274 1995 1703 1705
16. Buzaid A.C. Tinoco L. Ross M.I. Role of computed tomography in the staging of patients with local-regional metastases of melanoma J Clin Oncol 13 1995 2104 2108
17. Buzaid A.C. Sandler A.B. Mani S. Role of computed tomography in the staging of primary melanoma J Clin Oncol 11 1993 638 643
18. [abstract] Jillella A. Mani S. Nair B. The role for close follow-up of melanoma patients with AJCC Stages MR: a preliminary analysis Proc Am Soc Clin Oncol 14 1995 413
19. Basseres N. Grob J.J. Richard M.A. Cost-effectiveness of surveillance of Stage I melanoma: a retrospective appraisal based on a 10-year experience in a dermatology department in France Dermatology 191 1995 199 203
20. Berman C. Reintgen D. Radiologic imaging in malignant melanoma: a review Semin Surg Oncol 9 1993 232 238
21. Horgan K. Hugues L.E. Staging of melanoma Clin Radiol 48 1993 297 300
22. [letter] Campora E. Repetto L. Giunfini P. LDH in the follow-up of Stage I malignant melanoma Eur J Clin Oncol 24 1988 277 278
23. [letter] Finck S.J. Giuliano A.E. Morton D.L. LDH and melanoma Cancer 51 1982 840
24. Garg R. McPherson T.A. Lentle B. Usefulness of an elevated serum lactate dehydrogenase value as a marker for hepatic metastases in malignant melanoma Can Med Assoc J 120 1979 1114 1116
25. Khansur T. Sanders J. Das S.K. Evaluation of staging workup in malignant melanoma Arch Sung 124 1989 847 849
26. Ardizzoni A. Grimaldi A. Repetto L. Stage I–II melanoma: the value of metastatic work-up Oncology 44 1987 87 89
27. Iscoe N. Kersey P. Gapski J. Predictive value of staging: investigations in patients with clinical stage I malignant melanoma Plast Reconstr Surg 80 1987 233 237
28. Kostrubiak I. Whitley N.O. Aisner J. The use of computed body tomography in malignant melanoma JAMA 259 1988 2896 2898
29. Kersey P.A. Iscoe N.A. Gapski J.A.P. The value of staging and serial follow-up investigations in patients with completely resected, primary, cutaneous malignant melanoma Br J Surg 72 1985 614 617
30. Zartman G.M. Thomas M.R. Robinson W.A. Metastatic disease in patients with newly diagnosed malignant melanoma J Surg Oncol 35 1987 163 164
31. Eggermont A.M.M. Surveillance des malades atteints de melanome de stade I après exéresè de la tumeur primitive Ann Dermatol Venereol 122 1995 292 297
32. Clark W.H. Elder D.E. Guerry D. A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma Hum Pathol 15 1984 1147 1165
33. Rogers G.S. Kopf A.W. Rigel D.S. Hazard-rate analysis in stage I malignant melanoma Arch Dermatol 122 1986 999 1002
34. Gritzmann N. Czembirek H. Hajek P. Sonographie bei zervikalen Lymphknotenmetastasen Radiologie 27 1987 118 122
35. Fornage B.D. Lorigan J.G. Sonographic detection and fineneedle aspiration biopsy of nonpalpable recurrent or metastatic melanoma in subcutaneous tissues J Ultrasound Med 8 1989 421 424
36. Blessing C. Feine U. Geiger L. Positron emission tomography and ultrasonography: a comparative retrospective study assessing the diagnostic validity in lymph node metastases of malignant melanoma Arch Dermatol 131 1995 1394 1398
37. Reintgen D.S. Vollmer R. Tso C.Y. Prognosis for recurrent stage I malignant melanoma Arch Surg 122 1987 1338 1342
38. Rigel D.S. Friedman R.J. Kopf A.W. Importance of complete cutaneous examination for the detection of malignant melanoma J Am Acad Dermatol 14 1986 857 860
39. Schweizerische Gesellschaft fur dermatologie und venereologie: das primare maligne melanom der Haut Bull Med Suisses 74 1993 1021 1024
40. Orfanos C.E. Jung E.G. Rassner G. Stellungnahme und empfehlungen der kommission malignes melanom der deutschen dermatologishen gesellschaft zur diagnostik, behandlung und nachsorge des malignen melanoms des Haut Hautarzt 84 1994 285 291
41. Rumke P. van Everdingen J.J.E. Consensus on the management of melanoma of the skin in the Netherlands Eur J Cancer 28 1992 600 604
42. NIH Consensus Conference Diagnosis and treatment of early melanoma JAMA 268 1992 1314 1319
43. Boni R. Huch Boni R.A. Steinert H. Staging of metastatic melanoma by whole-body positron emission tomography using 2-fluorine-18-fluoro-2-deoxy-D-glucose Br J Dermatol 132 1995 556 562
44. Steinert H.C. Huch Boni R.A. Buck A. Malignant melanoma: staging with whole-body positron emission tomography and 2-(F-18)-fluoro-2-deoxy-D-glucose Radiology 195 1995 705 709
45. Hoon D.S.B. Wang Y. Dale P.S. Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay J Clin Oncol 13 1995 2109 2116
46. Battayani Z. Grob J.J. Xerri L. Polymerase chain reaction detection of circulating melanocytes as a prognostic in patients with melanoma Arch Dermatol 131 1995 443 447
47. Boni R. Huch Boni R.A. Steinert H. Anti-melanoma monoclonal antibody 225.285 immunoscintigraphy in metastatic melanoma Dermatology 191 1995 119 123
48. Guo H.B. Stoffel-Wagner B. Bierwith T. Clinical significance of serum S100 in metastatic malignant melanoma Eur J Cancer 31 1995 924 928
49. Muller C. Le Pape A. Musset M. Scintigraphy with 99mTechnicium-JOOIX acylated polygalactoside in melanoma recurrence Eur J Dermatol 5 1995 600 606
50. Curry B.J. Smith M.J. Hersey P. Detection and quantification of melanoma cells in the circulation of patients Melanoma Res 6 1996 45 54
51. Wang X. Heller R. VanVoorhis N. Detection of submicroscopic lymph node metastases with polymerase chain reaction in patients with malignant melanoma Ann Surg 220 1994 768 774
52. Rodot S. Darcourt J. Bussiere F. A radiolabeled iodobenzamide for malignant melanoma staging Melanoma Res 4 1994 307 312
53. Perrot J.L. Soler C. Tiffet O. Detection of malignant melanoma metastasis with 99mTc-sestamibi SPELT (single photon emission tomography) during follow-up of malignant melanoma in 17 patients Eur J Dermatol 6 1996 505 508
54. Barth A. Wanek L.A. Morton D.L. Prognostic factors in 1521 melanoma patients with distant metastases J Am Coll Surg 181 1995 193 201
55. Houghton A.N. Balch C.M. Treatment for advanced melanoma Balch C.M. Houghton A.N. Milton G.W. Cutaneous melanoma 2nd ed. 1992 JB Lippincott Philadelphia 477
56. Balch C.M. Houghton A.N. Peters L.J. Cutaneous melanoma DeVita V.T. Hellman S. Jr. Rosenberg S.A. Cancer: principles and practices of oncology 4th ed. 1993 JB Lippincott Philadelphia 1634
57. Tatra L. Dale P.S. Wanek L.A. Resection and adjuvant immunotherapy for melanoma metastasc to the lung and thorax J Thorac Cardiovasc Surg 110 1995 119 128